| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 7.60e-07 | 8 | 207 | 4 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.36e-06 | 9 | 207 | 4 | GO:0036374 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 1.85e-05 | 16 | 207 | 4 | GO:0008242 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 2.15e-05 | 6 | 207 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 2.15e-05 | 6 | 207 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 2.20e-05 | 146 | 207 | 9 | GO:0016810 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 4.77e-05 | 20 | 207 | 4 | GO:0070003 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC26A4 CLCN6 SLC9A7 SLC34A3 SLC39A10 SLC47A2 SLC8A1 SLC8A3 SLC46A3 SLC15A1 SLC47A1 SLC45A1 | 6.45e-05 | 296 | 207 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | monoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential | 1.07e-04 | 2 | 207 | 2 | GO:0099580 | |
| GeneOntologyMolecularFunction | polyspecific organic cation:proton antiporter activity | 1.07e-04 | 2 | 207 | 2 | GO:0140968 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 3.19e-04 | 3 | 207 | 2 | GO:1905060 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC26A4 SLC9A7 ABCC9 SLC34A3 SLC39A10 SLC47A2 SLC8A1 SLC8A3 SLC15A1 SLC47A1 SLC45A1 | 3.19e-04 | 301 | 207 | 11 | GO:0022853 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC26A4 AQP7B RYR2 CLCN6 KCNMA1 SLC9A7 APOL2 ABCC9 SLC34A3 SLC39A10 SLC47A2 SLC8A1 SLC8A3 SLC46A3 SLC15A1 SLC47A1 RIMBP2 SLC45A1 KCNH5 | 3.58e-04 | 758 | 207 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | antiporter activity | 5.99e-04 | 138 | 207 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | neurotrophin receptor activity | 1.05e-03 | 5 | 207 | 2 | GO:0005030 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 1.10e-03 | 20 | 207 | 3 | GO:0003746 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 1.86e-06 | 10 | 204 | 4 | GO:1901750 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 4.32e-06 | 12 | 204 | 4 | GO:1901748 | |
| GeneOntologyBiologicalProcess | glutathione metabolic process | 3.70e-05 | 63 | 204 | 6 | GO:0006749 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 3.98e-05 | 20 | 204 | 4 | GO:0006750 | |
| GeneOntologyBiologicalProcess | axonogenesis | RELN TRIO SPART PLXND1 TTC3 PTPRM CNP TRIM46 HSPG2 NTRK1 NTRK3 POU4F1 ARHGAP4 ABLIM1 EFNB1 SIPA1L1 PALLD | 5.08e-05 | 566 | 204 | 17 | GO:0007409 |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase catabolic process | 5.15e-05 | 8 | 204 | 3 | GO:0006208 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 5.15e-05 | 8 | 204 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | RELN TRIO SPART PLXND1 TTC3 PTPRM CNP TRIM46 HSPG2 NTRK1 NTRK3 POU4F1 CIT ARHGAP4 ABLIM1 EFNB1 SIPA1L1 SCRIB PALLD SOD1 | 5.61e-05 | 748 | 204 | 20 | GO:0048667 |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 5.91e-05 | 22 | 204 | 4 | GO:0019184 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 5.91e-05 | 22 | 204 | 4 | GO:0019370 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound catabolic process | 8.88e-05 | 46 | 204 | 5 | GO:0072529 | |
| GeneOntologyBiologicalProcess | peptide modification | 1.09e-04 | 10 | 204 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | RELN TRIO MYO9B SPART PLXND1 TTC3 PLAA PTPRM NBEAL2 PLEC CNP ARAP1 TRIM46 HSPG2 NTRK1 NTRK3 POU4F1 CIT ARHGAP4 ABLIM1 EFNB1 SIPA1L1 SCRIB ZRANB1 PALLD SOD1 | 1.32e-04 | 1194 | 204 | 26 | GO:0000902 |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 1.48e-04 | 11 | 204 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | RELN TRIO MYO9B SPART PLXND1 TTC3 PLAA PTPRM CNP TRIM46 HSPG2 NTRK1 NTRK3 POU4F1 CIT ARHGAP4 ABLIM1 EFNB1 SIPA1L1 PALLD | 1.90e-04 | 819 | 204 | 20 | GO:0120039 |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 2.12e-04 | 86 | 204 | 6 | GO:0008652 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | RELN TRIO MYO9B SPART PLXND1 TTC3 PLAA PTPRM CNP TRIM46 HSPG2 NTRK1 NTRK3 POU4F1 CIT ARHGAP4 ABLIM1 EFNB1 SIPA1L1 PALLD | 2.13e-04 | 826 | 204 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | axon development | RELN TRIO SPART PLXND1 TTC3 PTPRM CNP TRIM46 HSPG2 NTRK1 NTRK3 POU4F1 ARHGAP4 ABLIM1 EFNB1 SIPA1L1 PALLD | 2.31e-04 | 642 | 204 | 17 | GO:0061564 |
| GeneOntologyBiologicalProcess | relaxation of smooth muscle | 2.53e-04 | 13 | 204 | 3 | GO:0044557 | |
| GeneOntologyBiologicalProcess | nucleobase catabolic process | 2.53e-04 | 13 | 204 | 3 | GO:0046113 | |
| GeneOntologyBiologicalProcess | thymine metabolic process | 2.90e-04 | 3 | 204 | 2 | GO:0019859 | |
| GeneOntologyBiologicalProcess | thymine catabolic process | 2.90e-04 | 3 | 204 | 2 | GO:0006210 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 3.41e-04 | 34 | 204 | 4 | GO:0097107 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 3.41e-04 | 34 | 204 | 4 | GO:0043043 | |
| MousePheno | abnormal circulating glutathione level | 1.32e-05 | 5 | 155 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 1.32e-05 | 5 | 155 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 1.32e-05 | 5 | 155 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 1.32e-05 | 5 | 155 | 3 | MP:0012606 | |
| MousePheno | decreased circulating cysteine level | 4.53e-05 | 7 | 155 | 3 | MP:0030626 | |
| MousePheno | decreased cysteine level | 7.19e-05 | 8 | 155 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 7.19e-05 | 8 | 155 | 3 | MP:0004932 | |
| MousePheno | nervous | 1.07e-04 | 9 | 155 | 3 | MP:0008912 | |
| MousePheno | decreased abdominal adipose tissue amount | 1.09e-04 | 23 | 155 | 4 | MP:0008853 | |
| MousePheno | failure of copulatory plug deposition | 1.52e-04 | 10 | 155 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 1.52e-04 | 10 | 155 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 1.52e-04 | 10 | 155 | 3 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 2.07e-04 | 11 | 155 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 2.07e-04 | 11 | 155 | 3 | MP:0011130 | |
| Domain | WD_REPEATS_1 | FBXW10B EML6 PIK3R4 PLAA EML5 NBEAL2 HERC2 FBXW10 FBXW9 CORO2A WDR27 SEC31B NBAS EML1 TBL2 | 3.80e-07 | 278 | 202 | 15 | PS00678 |
| Domain | WD_REPEATS_2 | FBXW10B EML6 PIK3R4 PLAA EML5 NBEAL2 HERC2 FBXW10 FBXW9 CORO2A WDR27 SEC31B NBAS EML1 TBL2 | 3.98e-07 | 279 | 202 | 15 | PS50082 |
| Domain | WD_REPEATS_REGION | FBXW10B EML6 PIK3R4 PLAA EML5 NBEAL2 HERC2 FBXW10 FBXW9 CORO2A WDR27 SEC31B NBAS EML1 TBL2 | 3.98e-07 | 279 | 202 | 15 | PS50294 |
| Domain | WD40_repeat | FBXW10B EML6 PIK3R4 PLAA EML5 NBEAL2 HERC2 FBXW10 FBXW9 CORO2A WDR27 SEC31B EML1 TBL2 | 1.64e-06 | 272 | 202 | 14 | IPR001680 |
| Domain | - | FBXW10B EML6 PLXND1 PIK3R4 PLAA EML5 NBEAL2 FBXW10 FBXW9 CORO2A WDR27 SEC31B NBAS EML1 TBL2 | 3.61e-06 | 333 | 202 | 15 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | FBXW10B EML6 PLXND1 PIK3R4 PLAA EML5 NBEAL2 FBXW10 FBXW9 CORO2A WDR27 SEC31B NBAS EML1 TBL2 | 3.88e-06 | 335 | 202 | 15 | IPR015943 |
| Domain | WD40 | FBXW10B EML6 PIK3R4 PLAA EML5 NBEAL2 FBXW10 FBXW9 CORO2A WDR27 SEC31B EML1 TBL2 | 5.13e-06 | 259 | 202 | 13 | PF00400 |
| Domain | WD40 | FBXW10B EML6 PIK3R4 PLAA EML5 NBEAL2 FBXW10 FBXW9 CORO2A WDR27 SEC31B EML1 TBL2 | 7.42e-06 | 268 | 202 | 13 | SM00320 |
| Domain | WD40_repeat_dom | FBXW10B EML6 PIK3R4 PLAA EML5 NBEAL2 FBXW10 FBXW9 CORO2A WDR27 SEC31B EML1 TBL2 | 2.21e-05 | 297 | 202 | 13 | IPR017986 |
| Domain | HELP | 2.43e-05 | 6 | 202 | 3 | PF03451 | |
| Domain | HELP | 2.43e-05 | 6 | 202 | 3 | IPR005108 | |
| Domain | GGT_peptidase | 4.23e-05 | 7 | 202 | 3 | IPR000101 | |
| Domain | G_glu_transpept | 4.23e-05 | 7 | 202 | 3 | PF01019 | |
| Domain | G_GLU_TRANSPEPTIDASE | 4.23e-05 | 7 | 202 | 3 | PS00462 | |
| Domain | RCC1 | 5.62e-05 | 20 | 202 | 4 | PF00415 | |
| Domain | Calx_beta | 6.71e-05 | 8 | 202 | 3 | SM00237 | |
| Domain | RCC1_1 | 6.88e-05 | 21 | 202 | 4 | PS00625 | |
| Domain | RCC1_2 | 6.88e-05 | 21 | 202 | 4 | PS00626 | |
| Domain | RCC1_3 | 6.88e-05 | 21 | 202 | 4 | PS50012 | |
| Domain | WD40_repeat_CS | 7.57e-05 | 164 | 202 | 9 | IPR019775 | |
| Domain | - | 8.34e-05 | 22 | 202 | 4 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 8.34e-05 | 22 | 202 | 4 | IPR000408 | |
| Domain | Calx_beta | 9.98e-05 | 9 | 202 | 3 | IPR003644 | |
| Domain | Calx-beta | 9.98e-05 | 9 | 202 | 3 | PF03160 | |
| Domain | RCC1/BLIP-II | 1.00e-04 | 23 | 202 | 4 | IPR009091 | |
| Domain | MATE_fam | 1.16e-04 | 2 | 202 | 2 | IPR002528 | |
| Domain | MatE | 1.16e-04 | 2 | 202 | 2 | PF01554 | |
| Domain | Transl_elong_EF1A_euk/arc | 1.16e-04 | 2 | 202 | 2 | IPR004539 | |
| Domain | Tyr_kinase_rcpt_2_CS | 1.93e-04 | 11 | 202 | 3 | IPR002011 | |
| Domain | RECEPTOR_TYR_KIN_II | 2.55e-04 | 12 | 202 | 3 | PS00239 | |
| Domain | Quinoprotein_ADH-like_supfam | 2.65e-04 | 53 | 202 | 5 | IPR011047 | |
| Domain | Na_Ca_Ex | 3.47e-04 | 3 | 202 | 2 | IPR004836 | |
| Domain | Na_Ca_Ex_C-exten | 3.47e-04 | 3 | 202 | 2 | IPR032452 | |
| Domain | TPKR_C2 | 3.47e-04 | 3 | 202 | 2 | PF16920 | |
| Domain | Tyr_kinase_NGF_rcpt | 3.47e-04 | 3 | 202 | 2 | IPR020777 | |
| Domain | NTRK_C2 | 3.47e-04 | 3 | 202 | 2 | IPR031635 | |
| Domain | Na_Ca_ex_C | 3.47e-04 | 3 | 202 | 2 | PF16494 | |
| Domain | Histone_deAcase_II_euk | 6.88e-04 | 4 | 202 | 2 | IPR017320 | |
| Domain | VWC_out | 1.06e-03 | 19 | 202 | 3 | SM00215 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 5.78e-07 | 16 | 154 | 5 | MM14680 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 3.63e-05 | 35 | 154 | 5 | MM15815 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 5.47e-05 | 38 | 154 | 5 | MM14600 | |
| Pathway | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | 6.22e-05 | 39 | 154 | 5 | M3871 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 1.70e-04 | 26 | 154 | 4 | MM15190 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 1.98e-04 | 27 | 154 | 4 | MM15908 | |
| Pubmed | CYLD RELN TRAF2 GALNT2 TRIO PPRC1 EXTL3 TTC3 PIK3R4 NOMO2 SERGEF PLEC HERC2 KPNB1 KPNA3 CORO2A CCT2 ANKRD6 SEC31B CIT EEF1A1 EEF1A2 ABLIM1 HEATR6 SIPA1L1 ASB3 SCRIB SMAD2 SOD1 PCNT | 1.78e-10 | 1285 | 207 | 30 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD DLG5 EMC1 HDAC4 TRIO TRIP6 PIK3R4 MDN1 PLEC DPYSL3 NTRK3 ZNF629 PTPN21 HDAC7 EEF1A1 EEF1A2 ABLIM1 AASS SIPA1L1 TANC1 SCRIB PALLD | 1.18e-08 | 861 | 207 | 22 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRIO MYO9B PPRC1 TMEM187 PLXND1 EXTL3 TTC3 MDN1 NBEAL2 IFRD2 PLEC HERC2 GNAZ ARAP1 BAHCC1 HSPG2 FRAS1 CIT FBXO46 HDAC7 ADAMTS7 TANC1 SLC45A1 ESPL1 PCNT | 1.25e-08 | 1105 | 207 | 25 | 35748872 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EMC1 GALNT2 PLXND1 EXTL3 UBA1 POGLUT1 FBN2 LPCAT2 MSMO1 NOMO2 BTD EMC10 RFT1 APOL2 HSPG2 DPYSL3 FRAS1 NECTIN3 SLC39A10 LGALS3BP TGM2 PLA2R1 LOXL2 SCRIB PALLD SMAD2 | 1.52e-08 | 1201 | 207 | 26 | 35696571 |
| Pubmed | CYLD HDAC4 TRIO TTC3 DLGAP3 UBA1 MDN1 KCNMA1 SYN1 HERC2 CNP KPNB1 TRIM46 CIT EEF1A1 EEF1A2 ABLIM1 SIPA1L1 RIMBP2 EML1 QSER1 SCRIB PCNT | 1.87e-08 | 963 | 207 | 23 | 28671696 | |
| Pubmed | TRIO PIK3R4 DLGAP3 UBA1 CLCN6 SYN1 UQCRC2 PLEC GNAZ CNP KPNB1 KPNA3 TRIM46 DPYSL3 CORO2A POR CCT2 CIT EEF1A1 EEF1A2 ABLIM1 SIPA1L1 TRAPPC10 RIMBP2 TANC1 SCRIB SOD1 | 1.29e-07 | 1431 | 207 | 27 | 37142655 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | EMC1 SPART RCC2 PIK3R4 UBA1 MDN1 TELO2 NOMO2 KLHL13 UQCRC2 CNP KPNB1 KPNA3 RAD51C DDX12P ZBTB33 CCT2 LGALS3BP EEF1A1 EEF1A1P5 EEF1A2 AASS CCT6B SCRIB TBL2 | 1.48e-07 | 1257 | 207 | 25 | 37317656 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | EMC1 GALNT2 SPART FBN2 MDN1 PLAA INTS2 TELO2 HERC2 RFT1 KPNA3 POR SLC39A10 CIT ABLIM1 HEATR6 AASS SMAD2 PCNT | 1.53e-07 | 754 | 207 | 19 | 33060197 |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 2.08e-07 | 3 | 207 | 3 | 2573352 | |
| Pubmed | EMC1 GALNT2 RCC2 PIK3R4 SMYD4 UQCRC2 FRAS1 LONP2 MYO19 ZNF629 URGCP TGM2 ASB3 TANC1 QSER1 SCRIB PALLD | 4.24e-07 | 650 | 207 | 17 | 38777146 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | MTG1 EMC1 GALNT2 POGLUT1 AARS2 CLCN6 MSMO1 NOMO2 EMC10 UQCRC2 PLEC GNAZ PYCR3 KPNB1 RAD51C HSPG2 KIF16B POR CCT2 SLC39A10 LGALS3BP EEF1A1 TGM2 PLA2R1 LOXL2 OXNAD1 | 6.00e-07 | 1451 | 207 | 26 | 30550785 |
| Pubmed | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. | 7.52e-07 | 29 | 207 | 5 | 22424930 | |
| Pubmed | TRIO MYO9B EML6 TTC3 PLEC APOL2 KPNB1 CORO2A CDCP1 TRMU LOXL2 SCRIB | 8.34e-07 | 332 | 207 | 12 | 37433992 | |
| Pubmed | CYLD DLG5 EMC1 SPART TTC3 MDN1 TELO2 NOMO2 EMC10 UQCRC2 HERC2 PYCR3 FRAS1 KIF16B POR SLC39A10 LGALS3BP EEF1A2 NBAS EFNB1 TANC1 SCRIB ESPL1 TBL2 SOD1 PCNT | 9.48e-07 | 1487 | 207 | 26 | 33957083 | |
| Pubmed | 1.16e-06 | 14 | 207 | 4 | 18357469 | ||
| Pubmed | 1.27e-06 | 131 | 207 | 8 | 28634551 | ||
| Pubmed | CYLD SMYD4 UBA1 PLAA PLEC HERC2 PYCR3 HSPG2 ZBTB33 URGCP HERC4 ZRANB1 PALLD PCNT | 1.33e-06 | 481 | 207 | 14 | 28190767 | |
| Pubmed | EMC1 TRIO TRIP6 UBA1 PTPRH PTPRM TELO2 KCNMA1 UQCRC2 HERC2 KPNB1 KPNA3 DPYSL3 POR CCT2 PTPN21 SLC39A10 TANC1 SCRIB MAPK9 PCNT | 1.42e-06 | 1049 | 207 | 21 | 27880917 | |
| Pubmed | TRIO UBA1 MDN1 PLAA CNP KPNA3 RAD51C CORO2A DDX60 MYO19 MUC5B EEF1A2 TGM2 HEATR6 LOXL2 TBL2 | 1.49e-06 | 634 | 207 | 16 | 34591612 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | HLA-DMB PLXND1 EXTL3 LDAH GGT1 TMUB1 MDN1 MSMO1 INTS2 PTPRM EMC10 RFT1 PYCR3 NECTIN3 FBXO46 SLC47A2 EEF1A2 EFNB1 TMTC4 SLC45A1 TBL2 | 1.69e-06 | 1061 | 207 | 21 | 33845483 |
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 2.06e-06 | 5 | 207 | 3 | 12810527 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 2.06e-06 | 5 | 207 | 3 | 11089562 | |
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 9139708 | ||
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 2.06e-06 | 5 | 207 | 3 | 9546365 | |
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 2.06e-06 | 5 | 207 | 3 | 10751614 | |
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 10474818 | ||
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 10940879 | ||
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 9627710 | ||
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 12453183 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 2.06e-06 | 5 | 207 | 3 | 25132819 | |
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 23615310 | ||
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 11003618 | ||
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 10392451 | ||
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 19850887 | ||
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 2.06e-06 | 5 | 207 | 3 | 8755578 | |
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 2.06e-06 | 5 | 207 | 3 | 12225953 | |
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 7775425 | ||
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 2.06e-06 | 5 | 207 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 2.06e-06 | 5 | 207 | 3 | 24698228 | |
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 2.06e-06 | 5 | 207 | 3 | 18063838 | |
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 2.06e-06 | 5 | 207 | 3 | 11095909 | |
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 7641802 | ||
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 2891746 | ||
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 2.06e-06 | 5 | 207 | 3 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 2.06e-06 | 5 | 207 | 3 | 8566783 | |
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 30591459 | ||
| Pubmed | 2.06e-06 | 5 | 207 | 3 | 11795900 | ||
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 2.06e-06 | 5 | 207 | 3 | 19760322 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EMC1 GALNT2 MYO9B RCC2 UBA1 MDN1 AARS2 UQCRC2 PLEC HERC2 CNP KPNB1 CCT2 CIT LGALS3BP EEF1A1 ABLIM1 EFNB1 SCRIB PCNT | 3.69e-06 | 1024 | 207 | 20 | 24711643 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.77e-06 | 202 | 207 | 9 | 33005030 | |
| Pubmed | DLG5 EMC1 SPART PLXND1 RCC2 INTS2 TELO2 NBEAL2 ARAP1 KIF16B URGCP ARHGAP4 ESPL1 HERC4 | 4.00e-06 | 529 | 207 | 14 | 14621295 | |
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 4.10e-06 | 6 | 207 | 3 | 8101000 | |
| Pubmed | 4.10e-06 | 6 | 207 | 3 | 12163373 | ||
| Pubmed | 4.10e-06 | 6 | 207 | 3 | 22242126 | ||
| Pubmed | 4.10e-06 | 6 | 207 | 3 | 8663190 | ||
| Pubmed | 4.10e-06 | 6 | 207 | 3 | 14634009 | ||
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 4.10e-06 | 6 | 207 | 3 | 8104871 | |
| Pubmed | 4.10e-06 | 6 | 207 | 3 | 11463821 | ||
| Pubmed | 4.10e-06 | 6 | 207 | 3 | 10357931 | ||
| Pubmed | 4.10e-06 | 6 | 207 | 3 | 25326709 | ||
| Pubmed | 4.10e-06 | 6 | 207 | 3 | 17363454 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 5.58e-06 | 212 | 207 | 9 | 33853758 | |
| Pubmed | Human colostrum: identification of minor proteins in the aqueous phase by proteomics. | 6.20e-06 | 162 | 207 | 8 | 16502470 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | EMC1 TRIP6 RCC2 DLGAP3 FBN2 PTPRH PTPRM TELO2 UQCRC2 PYCR3 CNP KPNB1 PTPN21 LCP1 CCT6B MAPK9 ESPL1 TBL2 SMAD2 | 6.65e-06 | 974 | 207 | 19 | 28675297 |
| Pubmed | CYLD PPRC1 KLHL13 FRAS1 HEATR5A SLC39A10 ABLIM1 SIPA1L1 RIMBP2 ASB1 SCRIB PCNT | 6.76e-06 | 407 | 207 | 12 | 12693553 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ACAT2 GGT6 EPS8L1 GGT1 GGT3P UBA1 BTD C6 CNP KPNB1 HSPG2 SI CCT2 MUC5B LCP1 GGT2P LGALS3BP TGM2 CD14 SOD1 | 7.06e-06 | 1070 | 207 | 20 | 23533145 |
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 7.15e-06 | 7 | 207 | 3 | 32284594 | |
| Pubmed | 7.15e-06 | 7 | 207 | 3 | 36685533 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 7.15e-06 | 7 | 207 | 3 | 1968405 | |
| Pubmed | 7.15e-06 | 7 | 207 | 3 | 27775020 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DLG5 TRIP6 SPART RCC2 UBA1 PLAA AARS2 APOL2 ALDH6A1 CNP KPNB1 ZBTB33 CCT2 MUC5B LGALS3BP EEF1A1 TGM2 ABLIM1 HEATR6 SCRIB PALLD TBL2 SOD1 | 7.87e-06 | 1367 | 207 | 23 | 32687490 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CYLD DLG5 TRIO TRIP6 FBN2 NOMO2 PLEC HERC2 KPNB1 DPYSL3 CCT2 LCP1 AASS SIPA1L1 CCT6B TANC1 PCNT | 1.58e-05 | 853 | 207 | 17 | 28718761 |
| Pubmed | EMC1 GALNT2 EXTL3 RCC2 MDN1 AARS2 TELO2 UQCRC2 CNP KPNB1 KPNA3 CORO2A DDX60 MYO19 CCT2 LGALS3BP NBAS ABLIM1 AASS SIPA1L1 TRAPPC10 SCRIB TBL2 | 1.80e-05 | 1440 | 207 | 23 | 30833792 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TRAF2 TRIP6 ACAT2 MYO9B PIK3R4 UBA1 MDN1 PLAA UQCRC2 PLEC HERC2 PYCR3 CNP KPNB1 KPNA3 MYO19 CCT2 TGM2 CCT6B TANC1 SCRIB PALLD | 2.11e-05 | 1353 | 207 | 22 | 29467282 |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 2.31e-05 | 95 | 207 | 6 | 29643511 | |
| Pubmed | 2.42e-05 | 10 | 207 | 3 | 21681751 | ||
| Pubmed | 2.42e-05 | 10 | 207 | 3 | 23863468 | ||
| Pubmed | 2.52e-05 | 143 | 207 | 7 | 20424473 | ||
| Pubmed | 2.59e-05 | 257 | 207 | 9 | 16335952 | ||
| Pubmed | CYLD PPRC1 TTC3 PLAA EML5 INTS2 PLEC KPNA3 SLC39A10 ANKRD6 CDCP1 SIPA1L1 TRAPPC10 QSER1 ESPL1 HERC4 SMAD2 SOD1 PCNT | 2.92e-05 | 1084 | 207 | 19 | 11544199 | |
| Pubmed | 3.26e-05 | 331 | 207 | 10 | 29199018 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MTG1 TRAF2 EMC1 TTC3 MDN1 AARS2 TELO2 ECI2 UQCRC2 HERC2 APOL2 CNP MYO19 KIF16B POR CCT2 LGALS3BP NBAS AASS TANC1 ESPL1 TBL2 PCNT | 3.26e-05 | 1496 | 207 | 23 | 32877691 |
| Pubmed | Anatomical coupling of sensory and motor nerve trajectory via axon tracking. | 3.31e-05 | 11 | 207 | 3 | 21791286 | |
| Pubmed | Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. | 3.31e-05 | 11 | 207 | 3 | 8955272 | |
| Pubmed | Specificity of sensory-motor connections encoded by Sema3e-Plxnd1 recognition. | 3.31e-05 | 11 | 207 | 3 | 19421194 | |
| Pubmed | IL10RA ALLC DLG5 RYR2 ECI2 KPNA3 ABCC9 HDAC7 ABLIM1 SLC8A1 SLC46A3 TMEM45B SIPA1L1 ASB3 FGGY TBL2 | 3.32e-05 | 814 | 207 | 16 | 23251661 | |
| Pubmed | DLGAP3 UBA1 SYN1 UQCRC2 PLEC CNP KPNB1 DPYSL3 CCT2 EEF1A1 EEF1A2 | 3.33e-05 | 403 | 207 | 11 | 30562941 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 3.53e-05 | 2 | 207 | 2 | 14988081 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 17621824 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 24317696 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 3.53e-05 | 2 | 207 | 2 | 35776514 | |
| Pubmed | The organization of the human gene NCX1 encoding the sodium-calcium exchanger. | 3.53e-05 | 2 | 207 | 2 | 8921376 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 24327612 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 23836919 | ||
| Interaction | YWHAH interactions | CYLD DLG5 EMC1 HDAC4 TRIO TRIP6 PIK3R4 UBA1 AARS2 KCNMA1 PLEC DPYSL3 NTRK1 ZNF629 PTPN21 HDAC7 EEF1A1 EEF1A2 ABLIM1 AASS SIPA1L1 TRAPPC10 TANC1 SCRIB ZRANB1 PALLD PCNT | 1.46e-05 | 1102 | 201 | 27 | int:YWHAH |
| Interaction | UGGT1 interactions | EMC1 TRIO PTPRH PTPRM DNMT3B NTRK1 NTRK3 LGALS3BP EEF1A1P5 LOXL2 ZRANB1 | 2.52e-05 | 235 | 201 | 11 | int:UGGT1 |
| Interaction | LCOR interactions | GALNT2 HDAC4 EXTL3 TTC3 NBEAL2 SERGEF KPNB1 KPNA3 CCT2 ASB3 ZRANB1 | 3.31e-05 | 242 | 201 | 11 | int:LCOR |
| Interaction | CCDC8 interactions | GALNT2 MYO9B RCC2 UBA1 MDN1 AARS2 UQCRC2 PLEC HERC2 CNP KPNB1 CCT2 LGALS3BP EEF1A1 ABLIM1 EFNB1 SCRIB ZRANB1 PCNT | 3.32e-05 | 656 | 201 | 19 | int:CCDC8 |
| Interaction | FER1L6 interactions | 3.32e-05 | 7 | 201 | 3 | int:FER1L6 | |
| Interaction | PARD3 interactions | CYLD DLG5 HDAC4 TRIO NTRK3 NECTIN3 CIT SIPA1L1 TANC1 SCRIB ZRANB1 SMAD2 | 4.75e-05 | 298 | 201 | 12 | int:PARD3 |
| Interaction | YWHAZ interactions | CYLD DLG5 TRAF2 HDAC4 UBA1 NBEAL2 KCNMA1 SYN1 UQCRC2 PLEC HERC2 CNP ZBTB33 CORO2A NTRK1 ZNF629 PTPN21 HDAC7 EEF1A1 TGM2 ABLIM1 AASS LOXL2 SIPA1L1 TANC1 SCRIB ZRANB1 SOD1 PCNT | 5.03e-05 | 1319 | 201 | 29 | int:YWHAZ |
| Interaction | CDC42 interactions | MTG1 DLG5 TRAF2 EMC1 GALNT2 TRIO MYO9B RCC2 MDN1 INTS2 TELO2 UQCRC2 HERC2 CNP ARAP1 MYO19 POR NECTIN3 SLC39A10 CIT HDAC7 EFNB1 AASS QSER1 SCRIB MAPK9 ZRANB1 PALLD SOD1 | 5.31e-05 | 1323 | 201 | 29 | int:CDC42 |
| Interaction | YWHAE interactions | CYLD DLG5 HDAC4 ACAT2 TTC3 PIK3R4 DLGAP3 UBA1 AARS2 KCNMA1 SYN1 KPNB1 ZBTB33 NTRK1 ZNF629 PTPN21 HDAC7 EEF1A1 EEF1A2 ABLIM1 SLC8A1 SLC8A3 AASS LOXL2 SIPA1L1 TANC1 ZRANB1 SOD1 | 5.41e-05 | 1256 | 201 | 28 | int:YWHAE |
| Interaction | PFN1 interactions | CYLD DLG5 TRIO TRIP6 MYO9B NTRK1 EEF1A2 NBAS ABLIM1 LOXL2 ASB1 TANC1 ZRANB1 PALLD SOD1 PCNT | 5.46e-05 | 509 | 201 | 16 | int:PFN1 |
| Interaction | DPP3 interactions | 5.92e-05 | 42 | 201 | 5 | int:DPP3 | |
| Interaction | HSP90AA1 interactions | CYLD TRAF2 HDAC4 INSRR GGT1 SGK3 UBA1 KLHL13 UQCRC2 KPNB1 ANKK1 HSPG2 DDX60 NTRK1 NTRK3 CCT2 HEATR5A CIT LGALS3BP EEF1A1 TRIM10 AASS LOXL2 ASB3 SCRIB HERC4 ZRANB1 SBK2 | 5.96e-05 | 1263 | 201 | 28 | int:HSP90AA1 |
| Interaction | CCT7 interactions | CYLD EMC1 HDAC4 RCC2 PIK3R4 UQCRC2 FBXW9 NTRK1 CCT2 SEC31B LGALS3BP LOXL2 CCT6B SCRIB ESPL1 ZRANB1 SOD1 | 6.79e-05 | 575 | 201 | 17 | int:CCT7 |
| Interaction | SEC31B interactions | 7.33e-05 | 23 | 201 | 4 | int:SEC31B | |
| GeneFamily | WD repeat domain containing | FBXW10B EML6 PIK3R4 PLAA EML5 NBEAL2 FBXW10 FBXW9 CORO2A WDR27 SEC31B EML1 TBL2 | 1.29e-07 | 262 | 140 | 13 | 362 |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 2.33e-06 | 13 | 140 | 4 | 564 | |
| GeneFamily | Solute carriers | SLC26A4 SLC22A17 SLC9A7 SLC22A20P SLC34A3 SLC39A10 SLC47A2 SLC8A1 SLC8A3 SLC46A3 SLC15A1 SLC47A1 SLC45A1 | 1.24e-05 | 395 | 140 | 13 | 752 |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 7.16e-05 | 11 | 140 | 3 | 559 | |
| GeneFamily | Histone deacetylases, class IIA | 3.54e-04 | 4 | 140 | 2 | 992 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.60e-03 | 161 | 140 | 6 | 593 | |
| GeneFamily | Ankyrin repeat domain containing | 2.81e-03 | 242 | 140 | 7 | 403 | |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | GALNT2 TRIO HLA-DMB SPART PLXND1 TTC3 UBA1 GPR6 NTRK3 POU4F1 LCP1 NBAS SIPA1L1 ESPL1 | 1.63e-06 | 372 | 206 | 14 | M19261 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL | GGT6 EPS8L1 EXTL3 FAT2 MYO15B EML5 LPCAT2 KCNMA1 OPLAH KIF16B MUC5B CDCP1 TGM2 PLA2R1 CD14 LYPD3 CCT6B FGGY PALLD | 1.29e-05 | 775 | 206 | 19 | M45713 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | DLG5 EMC1 GALNT2 TRIO MYO9B EXTL3 BTD KCNMA1 ECI2 UQCRC2 HERC2 GNAZ RAD51C HSPG2 DPYSL3 POR WDR27 SLC46A3 LOXL2 SIPA1L1 FGGY SOD1 | 1.63e-05 | 1009 | 206 | 22 | M157 |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 2.38e-05 | 108 | 206 | 7 | MM1334 | |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 3.10e-05 | 200 | 206 | 9 | M9484 | |
| Coexpression | GSE13493_DP_VS_CD8POS_THYMOCYTE_DN | 3.10e-05 | 200 | 206 | 9 | M3315 | |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN | 3.10e-05 | 200 | 206 | 9 | M6185 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 5.30e-05 | 166 | 206 | 8 | M7009 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 5.30e-05 | 166 | 206 | 8 | M39026 | |
| Coexpression | GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN | 6.27e-05 | 170 | 206 | 8 | M2942 | |
| Coexpression | GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP | 6.81e-05 | 172 | 206 | 8 | M2945 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN | 9.00e-05 | 179 | 206 | 8 | M16932 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING | 1.15e-04 | 237 | 206 | 9 | M7068 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | CYLD PLXND1 SLC22A17 LPCAT2 BTD ALDH6A1 DPYD DPYSL3 FRAS1 SIPA1L1 | 1.19e-04 | 294 | 206 | 10 | M1804 |
| Coexpression | KAYO_AGING_MUSCLE_UP | 1.34e-04 | 242 | 206 | 9 | M16050 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_COL9A1_HIGH_CILIARY_BODY_CELLS | 1.49e-04 | 101 | 206 | 6 | M43627 | |
| Coexpression | GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN | 1.57e-04 | 194 | 206 | 8 | M4687 | |
| Coexpression | GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP | 1.80e-04 | 198 | 206 | 8 | M9704 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN | 1.87e-04 | 199 | 206 | 8 | M8044 | |
| Coexpression | GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP | 1.87e-04 | 199 | 206 | 8 | M8418 | |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.91e-04 | 150 | 206 | 7 | M9139 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | DRAM1 FBN2 LPCAT2 OSGIN2 FRAS1 CORO2A DDX60 SLC39A10 PLA2R1 TMEM45B AASS LOXL2 PALLD | 1.91e-04 | 504 | 206 | 13 | M2157 |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN | 1.93e-04 | 200 | 206 | 8 | M8037 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP | 1.93e-04 | 200 | 206 | 8 | M9598 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN | 1.93e-04 | 200 | 206 | 8 | M3405 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN | 1.93e-04 | 200 | 206 | 8 | M8427 | |
| Coexpression | GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP | 1.93e-04 | 200 | 206 | 8 | M7207 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 1.93e-04 | 200 | 206 | 8 | M6513 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP | 1.93e-04 | 200 | 206 | 8 | M4313 | |
| Coexpression | GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP | 1.93e-04 | 200 | 206 | 8 | M6988 | |
| ToppCell | CTRL-Myeloid|CTRL / Disease state, Lineage and Cell class | 4.10e-07 | 199 | 207 | 9 | 70b89a930709fdb91fde6f96106add8455b11618 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-07 | 160 | 207 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-07 | 160 | 207 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 174 | 207 | 8 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 178 | 207 | 8 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 180 | 207 | 8 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 180 | 207 | 8 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 2.45e-06 | 184 | 207 | 8 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.99e-06 | 189 | 207 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-06 | 191 | 207 | 8 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-06 | 192 | 207 | 8 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, condition lineage and cell class | 4.06e-06 | 197 | 207 | 8 | e3174e90ea6136f1aa3a4a185b86458e35d51fd4 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.38e-06 | 199 | 207 | 8 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 107 | 207 | 6 | 2f84089acc794b43ee59452dc8f90ca7261ebd41 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 107 | 207 | 6 | 0b45241cc52d10225966b49941efb66997184158 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-05 | 162 | 207 | 7 | 9d6931619f5eb847c79d00ff5ae031fef30fd55c | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-05 | 117 | 207 | 6 | c6fc72608d56a389bcd87b5dc98a11e39b79bcb2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-05 | 183 | 207 | 7 | 7e2bac8b005155888ff4b41ef2e1d975dc17abc7 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-05 | 186 | 207 | 7 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 187 | 207 | 7 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 188 | 207 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.97e-05 | 189 | 207 | 7 | cceca3d14dd559bbb2cb4b81ea12c2b62d18ee49 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-05 | 190 | 207 | 7 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-05 | 190 | 207 | 7 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.07e-05 | 190 | 207 | 7 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 3.07e-05 | 190 | 207 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 191 | 207 | 7 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-05 | 192 | 207 | 7 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-05 | 192 | 207 | 7 | e44e37e5aeba8628556020d05e1606b28e2faa4f | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.28e-05 | 192 | 207 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 3.39e-05 | 193 | 207 | 7 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.39e-05 | 193 | 207 | 7 | 1db487e5f81849740d57cc3e2b5739e8f7581efb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 194 | 207 | 7 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 194 | 207 | 7 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 3.62e-05 | 195 | 207 | 7 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 195 | 207 | 7 | 62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.62e-05 | 195 | 207 | 7 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 196 | 207 | 7 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 3.74e-05 | 196 | 207 | 7 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 196 | 207 | 7 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.74e-05 | 196 | 207 | 7 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | control-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.74e-05 | 196 | 207 | 7 | e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.74e-05 | 196 | 207 | 7 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.74e-05 | 196 | 207 | 7 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-05 | 197 | 207 | 7 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | background-Kupffer_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.12e-05 | 199 | 207 | 7 | 91d229f3515d49639bcb5505e6aec4a9abade81c | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, condition lineage and cell class | 4.12e-05 | 199 | 207 | 7 | 1b17e6d5e6b994dec65efae2667f4f1f438161b1 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 207 | 7 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 207 | 7 | d46a19274c2836ce7494790ce513764dedcadc79 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 207 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 207 | 7 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial-Glia_progenitor_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 207 | 7 | 0b91c8da21ba488109f15c9b927c1dcaf8c6b0ae | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related-Oligodendrocyte/OPC|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 207 | 7 | 4db894cfb80fd1f9e01133f345eefd78edd4bc43 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 207 | 7 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 207 | 7 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.27e-05 | 150 | 207 | 6 | 6f7087a051a2f05c5611ff65a945c01736d5ec2b | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Mgp-Endothelial_Tip.Dcn.Mgp-Penk_(Penk)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.73e-05 | 94 | 207 | 5 | 8fb9adf0db3b0007204716869d895700cbdc6231 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.83e-05 | 152 | 207 | 6 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | Adult-Epithelial-basal_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.12e-05 | 153 | 207 | 6 | 9ee3e7f3f19a2474283c1c79045269686f35a541 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.36e-05 | 157 | 207 | 6 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | Healthy/Control-CD8+_T_naive|World / Disease group and Cell class | 9.69e-05 | 158 | 207 | 6 | 70680b29428b6bf882b1fae36f924b775961176b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.91e-05 | 52 | 207 | 4 | d654e2b77c53ed5319015598b68a20bf4416380c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Unfolded_protein_responsible_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.09e-04 | 101 | 207 | 5 | ae650e96b93a0d2f0a19ffaf37f21f02fb20651d | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.15e-04 | 163 | 207 | 6 | 13f76f2979558f5cd27fbfd1659b413b3cac18f5 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.23e-04 | 165 | 207 | 6 | d8b0a9b6f704b98e8f0412c11739879a26c036e2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 166 | 207 | 6 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 166 | 207 | 6 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 167 | 207 | 6 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.43e-04 | 107 | 207 | 5 | fc07dd90f280191bd643398eac5c8273651d0925 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.45e-04 | 170 | 207 | 6 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 170 | 207 | 6 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 170 | 207 | 6 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 172 | 207 | 6 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 172 | 207 | 6 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 173 | 207 | 6 | 94f99f7e7813d6e53e0bedf97087400b1bf00129 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 173 | 207 | 6 | 2978c744d3c8dcaa2b9bb225abf846f82e8f9176 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 173 | 207 | 6 | 23d4a315a0ad5c6fc77bcfc18b6c1ff55be99e8f | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 173 | 207 | 6 | 03b50b2376d353748a32bf14a9fc8341ea61dbca | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 173 | 207 | 6 | 12da47b90aecedaa31764ff7ddb853ee39123e9d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-04 | 174 | 207 | 6 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | 10x5'-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.64e-04 | 174 | 207 | 6 | 05525bf0a2bde2be4f7c147b17a24530ce8819e0 | |
| ToppCell | 10x5'-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 1.64e-04 | 174 | 207 | 6 | e94c980b25edfd0e8598c416828801fcc00e8ead | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 175 | 207 | 6 | c1a8a55af825d5913095f919fa860828df9c273e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 175 | 207 | 6 | 78b453e220218c84557f244ef7a760e4a1952761 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.75e-04 | 176 | 207 | 6 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-04 | 177 | 207 | 6 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-04 | 177 | 207 | 6 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-9|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.80e-04 | 177 | 207 | 6 | ae55773c531099a9e94f44f01ba48b5e71dddc53 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.80e-04 | 177 | 207 | 6 | db6de487ef7976b444afadbf3ac60b3259925566 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-04 | 177 | 207 | 6 | a0ff337f11bdb11959ac71805ff94be6b4ec1083 | |
| ToppCell | facs-Heart-LA-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 177 | 207 | 6 | a3f8c26d54e44688bbd678ac7ef55d8ad172617d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-04 | 179 | 207 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.91e-04 | 179 | 207 | 6 | 5122fc794509492afde4af8b1b76d51e3070ef05 | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.91e-04 | 179 | 207 | 6 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 179 | 207 | 6 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.91e-04 | 179 | 207 | 6 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-04 | 114 | 207 | 5 | 670c9802a59b39241abf6f2c12a3d1844c7db5e5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.97e-04 | 180 | 207 | 6 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A | TRIO EPS8L1 EXTL3 APOL2 KPNB1 HSPG2 DPYD PTPN21 ABLIM1 EML1 HERC4 | 1.58e-06 | 194 | 205 | 11 | 6921_UP |
| Drug | Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | TRAF2 EPS8L1 EXTL3 PAOX PLEC GNAZ ARAP1 BAHCC1 LONP2 FBXO46 SLC47A1 | 1.74e-06 | 196 | 205 | 11 | 5018_DN |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A | EPS8L1 FBN2 TELO2 PLEC ALDH6A1 CORO2A KIF16B TGM2 CCT6B ASB1 HERC4 | 1.74e-06 | 196 | 205 | 11 | 6568_UP |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; HL60; HT_HG-U133A | CYLD DRAM1 EPS8L1 PAOX FBN2 CLCN6 BTD NBEAL2 BAHCC1 ARHGAP4 ASB1 | 1.93e-06 | 198 | 205 | 11 | 2346_DN |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.20e-05 | 196 | 205 | 10 | 2377_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; HL60; HT_HG-U133A | 1.20e-05 | 196 | 205 | 10 | 2207_UP | |
| Drug | carbon tetrachloride | 1.21e-05 | 240 | 205 | 11 | CID000005943 | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.26e-05 | 197 | 205 | 10 | 3629_DN | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.26e-05 | 197 | 205 | 10 | 3575_DN | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; HL60; HT_HG-U133A | RELN SPART APOBEC3G EPS8L1 EXTL3 SLC22A17 ADORA1 KCNMA1 NTRK1 HDAC7 | 1.31e-05 | 198 | 205 | 10 | 2496_UP |
| Drug | Ricinine [524-40-3]; Up 200; 24.4uM; MCF7; HT_HG-U133A | CYLD MYO9B SLC26A4 EPS8L1 EXTL3 PLEC PYCR3 LONP2 PTPN21 FGGY | 1.31e-05 | 198 | 205 | 10 | 6206_UP |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; MCF7; HT_HG-U133A | CYLD EMC1 MYO9B CLCN6 CORO2A PTPN21 ANKRD6 TRMU SIPA1L1 HERC4 | 1.37e-05 | 199 | 205 | 10 | 5426_DN |
| Drug | cupric chloride | ALLC ACAT2 EML6 ZP3 UBA1 CLCN6 PTPRM HSPG2 DPYSL3 POR PHYHD1 URGCP NBAS TMTC4 HERC4 PALLD SOD1 PCNT | 1.49e-05 | 623 | 205 | 18 | ctd:C029892 |
| Drug | Guanidine | 3.90e-05 | 8 | 205 | 3 | ctd:D019791 | |
| Drug | glutamate | RELN GGT1 RYR2 SGK3 ADORA1 MDN1 CLCN6 KCNMA1 SYN1 UQCRC2 PLEC PYCR3 CTU1 OPLAH DPYSL3 NTRK3 CIT EEF1A2 TRMU ARHGAP4 AASS SOD1 | 6.02e-05 | 962 | 205 | 22 | CID000000611 |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 6.13e-05 | 191 | 205 | 9 | 3976_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 6.13e-05 | 191 | 205 | 9 | 6776_UP | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 6.91e-05 | 194 | 205 | 9 | 4804_DN | |
| Drug | 5-fluorocytidine | 6.96e-05 | 25 | 205 | 4 | CID000016861 | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 7.19e-05 | 195 | 205 | 9 | 2865_UP | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A | 7.19e-05 | 195 | 205 | 9 | 3135_DN | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 7.19e-05 | 195 | 205 | 9 | 5277_DN | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 7.19e-05 | 195 | 205 | 9 | 6828_DN | |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 7.47e-05 | 196 | 205 | 9 | 5741_DN | |
| Drug | indomethacin, USP; Up 200; 100uM; SKMEL5; HG-U133A | 7.47e-05 | 196 | 205 | 9 | 503_UP | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; PC3; HT_HG-U133A | 7.47e-05 | 196 | 205 | 9 | 4469_DN | |
| Drug | Anabasine [494-52-0]; Up 200; 24.6uM; MCF7; HT_HG-U133A | 7.47e-05 | 196 | 205 | 9 | 6774_UP | |
| Drug | PHA-00665752 [477575-56-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 7.77e-05 | 197 | 205 | 9 | 6578_UP | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A | 7.77e-05 | 197 | 205 | 9 | 6563_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 7.77e-05 | 197 | 205 | 9 | 6611_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 7.77e-05 | 197 | 205 | 9 | 3412_UP | |
| Drug | cinchonidine | 8.07e-05 | 2 | 205 | 2 | ctd:C041622 | |
| Drug | ethohexadiol | 8.07e-05 | 2 | 205 | 2 | ctd:C004917 | |
| Drug | Sulfamerazine | 8.07e-05 | 2 | 205 | 2 | ctd:D013416 | |
| Drug | triethylmethylammonium | 8.07e-05 | 2 | 205 | 2 | ctd:C043900 | |
| Drug | Midodrine | 8.07e-05 | 2 | 205 | 2 | ctd:D008879 | |
| Drug | NVP-AUY922 | 8.07e-05 | 2 | 205 | 2 | CID010096043 | |
| Drug | Nialamide | 8.07e-05 | 2 | 205 | 2 | ctd:D009526 | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 7509_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 3869_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 2269_UP | |
| Drug | Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; MCF7; HT_HG-U133A | SERGEF KCNMA1 ALDH6A1 CRAT HDAC7 ARHGAP4 TGM2 SLC15A1 ADAMTS7 | 8.08e-05 | 198 | 205 | 9 | 4393_UP |
| Drug | Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 7496_UP | |
| Drug | Probucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 3223_DN | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; HL60; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 2400_DN | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 1699_UP | |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 6836_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 2329_UP | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 5349_DN | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 7339_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 8.73e-05 | 200 | 205 | 9 | 6521_DN | |
| Drug | Propantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A | 8.73e-05 | 200 | 205 | 9 | 3352_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 8.73e-05 | 200 | 205 | 9 | 3276_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A | 8.73e-05 | 200 | 205 | 9 | 7002_DN | |
| Drug | Hcys | 9.48e-05 | 250 | 205 | 10 | CID000000594 | |
| Drug | AC1L1E6T | 1.10e-04 | 28 | 205 | 4 | CID000002666 | |
| Drug | Wen-pi-tang-Hab-Wu-ling-san | 1.13e-04 | 11 | 205 | 3 | ctd:C521629 | |
| Drug | HOAt | 1.13e-04 | 11 | 205 | 3 | CID000181649 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 3.16e-07 | 3 | 202 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | Schizophrenia | IL10RA RELN HDAC4 MYO9B CSMD2 ADORA1 PLAA EML5 SYN1 APOL2 CNP DNMT3B KPNA3 ANKK1 DPYD NTRK1 NTRK3 PTPN21 TGM2 PCNT | 3.18e-06 | 883 | 202 | 20 | C0036341 |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 1.08e-05 | 7 | 202 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 1.73e-05 | 8 | 202 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | GALNT2 MYO9B FBN2 CLCN6 PTPRH APOL2 ALDH6A1 PYCR3 KPNB1 NTRK1 MYO19 LCP1 ANKRD6 CRAT CIT EEF1A1 TRIM10 EEF1A1P5 TRMU SCGB1D1 ASB3 SLC47A1 TBL2 | 5.43e-05 | 1347 | 202 | 23 | EFO_0005192 |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 6.24e-05 | 61 | 202 | 5 | DOID:3587 (is_marker_for) | |
| Disease | pancreatic cancer (is_marker_for) | 7.06e-05 | 101 | 202 | 6 | DOID:1793 (is_marker_for) | |
| Disease | N-acetyl-isoputreanine measurement | 8.59e-05 | 13 | 202 | 3 | EFO_0800107 | |
| Disease | epilepsy (implicated_via_orthology) | 1.37e-04 | 163 | 202 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | infantile liver failure syndrome (is_implicated_in) | 1.39e-04 | 3 | 202 | 2 | DOID:0080716 (is_implicated_in) | |
| Disease | serum metabolite measurement | GALNT2 TRIO ZP3 GGT1 PAOX PTPRH PYCR3 OPLAH DPYD FMO3 PHYHD1 LCP1 CRAT CIT EEF1A2 TMEM45B GADL1 | 2.93e-04 | 945 | 202 | 17 | EFO_0005653 |
| Disease | Obesity | 5.52e-04 | 205 | 202 | 7 | C0028754 | |
| Disease | dry eye syndrome (implicated_via_orthology) | 6.87e-04 | 6 | 202 | 2 | DOID:10140 (implicated_via_orthology) | |
| Disease | Ischemia | 9.13e-04 | 28 | 202 | 3 | C0022116 | |
| Disease | retinal vasculature measurement | TRIO KCNMA1 HERC2 DNMT3B HSPG2 FBXO46 N6AMT1 SLC47A1 RIMBP2 PALLD SMAD2 | 9.30e-04 | 517 | 202 | 11 | EFO_0010554 |
| Disease | level of oxylipin in blood plasma | 9.57e-04 | 7 | 202 | 2 | OBA_2050338 | |
| Disease | Grand Mal Status Epilepticus | 1.17e-03 | 67 | 202 | 4 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 1.17e-03 | 67 | 202 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 1.17e-03 | 67 | 202 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 1.17e-03 | 67 | 202 | 4 | C0751523 | |
| Disease | Petit mal status | 1.17e-03 | 67 | 202 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 1.17e-03 | 67 | 202 | 4 | C0393734 | |
| Disease | Status Epilepticus | 1.23e-03 | 68 | 202 | 4 | C0038220 | |
| Disease | excessive daytime sleepiness measurement | 1.48e-03 | 33 | 202 | 3 | EFO_0007875 | |
| Disease | kallikrein-14 measurement | 1.63e-03 | 9 | 202 | 2 | EFO_0020513 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement | 1.76e-03 | 35 | 202 | 3 | EFO_0005199, EFO_0005208 | |
| Disease | Carotid Circulation Transient Ischemic Attack | 2.02e-03 | 10 | 202 | 2 | C0751019 | |
| Disease | Transient Ischemic Attack | 2.02e-03 | 10 | 202 | 2 | C0007787 | |
| Disease | celiac disease (is_implicated_in) | 2.02e-03 | 10 | 202 | 2 | DOID:10608 (is_implicated_in) | |
| Disease | Crescendo Transient Ischemic Attacks | 2.02e-03 | 10 | 202 | 2 | C0751021 | |
| Disease | Transient Ischemic Attack, Vertebrobasilar Circulation | 2.02e-03 | 10 | 202 | 2 | C0751020 | |
| Disease | Brain Stem Ischemia, Transient | 2.02e-03 | 10 | 202 | 2 | C0751022 | |
| Disease | Posterior Circulation Transient Ischemic Attack | 2.02e-03 | 10 | 202 | 2 | C0472381 | |
| Disease | Transient Ischemic Attack, Anterior Circulation | 2.02e-03 | 10 | 202 | 2 | C1527335 | |
| Disease | Transient Cerebral Ischemia | 2.02e-03 | 10 | 202 | 2 | C0917805 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.04e-03 | 257 | 202 | 7 | DOID:10652 (is_marker_for) | |
| Disease | schizophrenia (is_implicated_in) | 2.05e-03 | 78 | 202 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | Tinnitus | 2.05e-03 | 130 | 202 | 5 | HP_0000360 | |
| Disease | response to statin, myopathy | 2.46e-03 | 11 | 202 | 2 | EFO_0004145, GO_0036273 | |
| Disease | Tachycardia, Ventricular | 2.46e-03 | 11 | 202 | 2 | C0042514 | |
| Disease | pulmonary fibrosis | 2.46e-03 | 11 | 202 | 2 | EFO_0009448 | |
| Disease | Autism Spectrum Disorders | 2.80e-03 | 85 | 202 | 4 | C1510586 | |
| Disease | heat shock protein beta-1 measurement | 2.94e-03 | 12 | 202 | 2 | EFO_0010595 | |
| Disease | level of Diacylglycerol (18:1_18:2) in blood serum | 2.94e-03 | 12 | 202 | 2 | OBA_2045171 | |
| Disease | Malignant neoplasm of breast | HDAC4 TTC3 SGK3 PIK3R4 HERC2 CTU1 DNMT3B RAD51C DPYD KIF16B HDAC7 TGM2 SLC8A3 TMTC4 LOXL2 SIPA1L1 | 3.08e-03 | 1074 | 202 | 16 | C0006142 |
| Disease | salicylurate measurement | 3.46e-03 | 13 | 202 | 2 | EFO_0010532 | |
| Disease | creatinine measurement | DLGAP3 KCNMA1 PLEC APOL2 OPLAH KPNA3 TRIM46 POR SLC34A3 LCP1 SLC47A2 EEF1A2 SLC8A1 ADAMTS7 SLC47A1 | 3.69e-03 | 995 | 202 | 15 | EFO_0004518 |
| Disease | biliary atresia (is_marker_for) | 4.02e-03 | 14 | 202 | 2 | DOID:13608 (is_marker_for) | |
| Disease | Celiac Disease | 4.11e-03 | 47 | 202 | 3 | C0007570 | |
| Disease | susceptibility to pneumonia measurement | 4.50e-03 | 97 | 202 | 4 | EFO_0008410 | |
| Disease | severe aplastic anemia | 4.62e-03 | 15 | 202 | 2 | EFO_0006927 | |
| Disease | triacylglycerol 52:3 measurement | 4.62e-03 | 15 | 202 | 2 | EFO_0010415 | |
| Disease | Weight Gain | 5.37e-03 | 102 | 202 | 4 | C0043094 | |
| Disease | androstenedione measurement, estrone measurement | 6.64e-03 | 18 | 202 | 2 | EFO_0007970, EFO_0007972 | |
| Disease | sweet liking measurement | 6.64e-03 | 18 | 202 | 2 | EFO_0010156 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEETLRVGDCAVFLS | 2511 | Q9P281 | |
| GAAAAVAGITCSVVE | 156 | Q9BQE5 | |
| TIEAEAGCTIGLHFL | 1301 | Q7Z408 | |
| AGCTIGLHFLVFDTE | 1306 | Q7Z408 | |
| VECLEVLVGTGTAAE | 501 | Q9UBC3 | |
| EACHQFITGKVLEAG | 286 | O14639 | |
| CFIVSLAVADVAVGA | 46 | P30542 | |
| ADLVAIAFGGVCVGF | 196 | Q8N6M5 | |
| CIIESVFEGEGSATL | 221 | Q9H5V8 | |
| GFLEGRHAELCFLDV | 251 | Q9HC16 | |
| HGEEAVVSALLQCGA | 636 | Q8NFD2 | |
| HGCEAAFVSLLVEFG | 246 | Q9Y576 | |
| TCLGELGAIAQVHAE | 186 | Q14195 | |
| GHAGSVRALFLCEEE | 451 | Q5XX13 | |
| AICDISADTGGSIEF | 351 | Q9UDR5 | |
| TLQFIVAEDGSCGLV | 326 | P43155 | |
| IVLGAGDTAFDCATS | 336 | Q12882 | |
| TFALLFVHVCEIAEG | 76 | O60706 | |
| FVHVCEIAEGIVSDS | 81 | O60706 | |
| AIHEACFGGREAIIN | 281 | A6NGH8 | |
| LVGIGADDAFVLCDV | 566 | Q96F81 | |
| SLVGCGHFAEVQVVR | 101 | O14578 | |
| TCHTVSGTFEEAEGL | 696 | Q9UKP4 | |
| GNTEIIAALIHEGCA | 86 | Q9Y2G4 | |
| CAAHGEIVSETLIAF | 21 | Q8IYR0 | |
| EHCIFENIGGTVTLI | 501 | Q96L93 | |
| ELGQVVECSLDFGLV | 4186 | Q9HC84 | |
| ITFCSALDDILGGGV | 101 | O43502 | |
| IEGLSHEVIVSAACG | 196 | Q9P258 | |
| VAEGQTLDLSCVVAG | 2256 | P98160 | |
| VVGHAVEFECLALGD | 3501 | P98160 | |
| CFLEEVGSQALVAGS | 391 | P22695 | |
| VDDILAATAAACGVT | 851 | Q2KHR3 | |
| EESQTATLLCLVFGG | 341 | Q7Z6M1 | |
| ALSGGVTAVSEVFLC | 476 | Q96AA3 | |
| HLFAGTELTDLAVGC | 311 | Q8N130 | |
| GHAGSVRALFLCEEE | 451 | O95170 | |
| VHDGGALLAFVCGVV | 121 | Q8N682 | |
| GSVAEETLGCTFVLS | 396 | Q8N635 | |
| GTGFFIGIVLLCDHV | 196 | Q15800 | |
| SRCSGVEHFILEVIG | 106 | Q8NBL1 | |
| GGSAVDAAIAALLCV | 61 | A6NGU5 | |
| AQGIVCAAFDTVLGI | 36 | P45984 | |
| GDVFRGLQVVEHACS | 136 | Q02252 | |
| AAAVVGAAGLASICD | 246 | Q01851 | |
| FCLAEGHVASVDSVL | 166 | Q5XUX1 | |
| FGVSVAVGLAVFACL | 416 | P04629 | |
| ADIVATGFSVCGRIS | 401 | Q5JPE7 | |
| ASTIAEIIEECGGLE | 446 | O00505 | |
| FELGVGTIDACGHLD | 226 | Q17RR3 | |
| TLLEVGQIAVCSFGE | 5416 | Q9NU22 | |
| AIFEDGTIFEGIDCV | 311 | P31513 | |
| LIDVCGGSVTADFQV | 3446 | Q86XX4 | |
| DVLLCVSGTVIAGEN | 76 | P46095 | |
| HSAGAARLAVGCVVE | 766 | P56524 | |
| FHRIALGGVCDQSDI | 396 | Q86WA8 | |
| HVVVCIFGDVSSALI | 841 | Q12791 | |
| VQGEDALGFCGHTVI | 161 | Q08380 | |
| AVCEHFGVEATGEES | 226 | P16435 | |
| RGHGLFCDVTVIVED | 26 | Q86T24 | |
| SAGVTVELCAGLVDQ | 96 | O95848 | |
| GVSIAVGLAAFACVL | 431 | Q16288 | |
| HVVCALSGGVDSAVA | 6 | O75648 | |
| EACGLVETIHISAAG | 641 | Q96H55 | |
| IEVVDVAAGGAHSAC | 4091 | O95714 | |
| LTEAGIHVFILGCFS | 26 | P40933 | |
| ICVSAAAILHFSGGE | 136 | A0A075B734 | |
| AVDGADIYIVEHGCA | 996 | Q2LD37 | |
| CLDTLGHFADGVVGV | 456 | Q10471 | |
| GESVDALCFVVSGSL | 581 | Q8NCM2 | |
| DLVSASVVCRELGFG | 356 | Q9Y4K0 | |
| VIFDEVHCLGGEIGA | 886 | Q8IY21 | |
| ALCGTVLDHLVGEET | 221 | Q9BT17 | |
| ASAIGCHVVNIGAED | 201 | P13796 | |
| IIHCSVNESLGAAVG | 1231 | Q9Y4D7 | |
| GCFDIELETGLLTVA | 761 | Q9NYQ8 | |
| ARDCGASGFHVDVVV | 356 | Q6PJ61 | |
| GIFLFGNTEISLEAC | 86 | Q9H342 | |
| LGCLSEAEELVVGSA | 171 | Q7Z412 | |
| CGLRHTVFVLDDGTV | 41 | Q5GLZ8 | |
| DSDLFHLIGVICGLA | 791 | Q5GLZ8 | |
| LSDGAVAGCRVAAVF | 216 | P47871 | |
| CEDGVSDLVCFVSGL | 291 | Q9H0H0 | |
| LCGGNLHGVFVAEVE | 1516 | Q8TDM6 | |
| GFLEEILAVCFDSSG | 1156 | Q6AI08 | |
| SLLTSGEVGEFCVQV | 191 | Q13651 | |
| HGQLFSGCVALVDVG | 271 | P98088 | |
| TATHDGGFLSLECEI | 436 | A2RRP1 | |
| DALLDSVEVGLSCVG | 551 | O95613 | |
| CTEAVGAVETIHGQF | 61 | O95274 | |
| VCGSTGDALVFIEKA | 2346 | P78509 | |
| DISIGACLEGIFVKH | 231 | Q16825 | |
| GVSVALGTIEEVCSF | 376 | O43422 | |
| CEGGDLHTLIIAEAF | 321 | Q8WX93 | |
| HSTFFDGIACVVAGL | 146 | Q7L5N7 | |
| TLDCEVAVRVGGEFF | 146 | Q96HP4 | |
| FAEVLGVECRGGSTL | 1376 | Q96JP2 | |
| IVGSGLTAADAVLCA | 306 | Q9Y236 | |
| SAVFGGHEDCLEILL | 286 | Q9Y575 | |
| TGAGGFVAHVESTCL | 16 | P28068 | |
| AIGVCTGLVGLFVDF | 86 | P51797 | |
| CVSAVEVEIHAGGLN | 51 | P08571 | |
| FLLESCTEFGGVTQH | 1056 | Q14674 | |
| SASKLFGVVCAHVGE | 781 | Q86XA9 | |
| FEGVTAIIFCVELSG | 216 | P19086 | |
| FLISGVTLDNCVEVG | 186 | Q9P2N7 | |
| EDVEISCLTGFETVG | 666 | P13671 | |
| EVESVLVGAAVLGAC | 481 | Q96C11 | |
| CAVLIVAAGVGEFEA | 111 | Q05639 | |
| CAVLIVAAGVGEFEA | 111 | P68104 | |
| GCATRLFEALEVGAV | 446 | O43909 | |
| VDAGVGAALCLAVVH | 126 | Q6P531 | |
| CAAFEAEVLHTVLAG | 31 | Q7Z7A3 | |
| HFIAVVTECAGGGAF | 46 | Q92828 | |
| LEAVCGSVFGELESQ | 471 | O95886 | |
| SKVALFAAVGAGCVI | 236 | P98172 | |
| AGVEAERVVEFSCGH | 656 | Q92771 | |
| CGQEITEATGIFEFH | 471 | P43251 | |
| ITLGCAADVEAVQTG | 331 | P09543 | |
| TDGVVACAAGLIGDL | 811 | Q14974 | |
| TFRAVLHSVEGGECE | 396 | Q12894 | |
| AQDLVGCTHVEGSLI | 341 | P14616 | |
| CAVLIVAAGVGEFEA | 111 | Q5VTE0 | |
| LTAGEACAQGLVTEV | 306 | O75521 | |
| LHVIGIGFFDRAVTC | 316 | O00423 | |
| CVSHSGISLVTGDDF | 1896 | Q05BV3 | |
| CLVSVGLDDFHSIVF | 786 | Q6ZMW3 | |
| GEACGTVGLLLEHSF | 46 | Q5UCC4 | |
| QHLSGACGVVDEAVL | 221 | Q8N766 | |
| ASFLGIGTENVCFVE | 226 | Q6ZQY3 | |
| VLALEGGHDLTAICD | 836 | Q8WUI4 | |
| EFHGLCSSGVGITVD | 751 | P35556 | |
| GETIESGTVIFCDVL | 241 | Q9NQC7 | |
| LVTFCLGEDDGVHTV | 41 | Q8TE68 | |
| SFGATAILAGLAVCV | 491 | A6NK97 | |
| LTCGEVVFSVTGLEF | 591 | P46059 | |
| EFCVGLSLGAHSAIV | 106 | P0C263 | |
| LTGGISTSIAVFCHE | 696 | Q9ULF5 | |
| NIDSVLIDCFTGGHD | 406 | Q9Y2W3 | |
| EIGCVVDAASGLLTF | 1506 | Q92736 | |
| SVGHVVLTDFGLCKE | 296 | Q96BR1 | |
| FGEIEECTIHFRVQG | 1566 | Q5VV67 | |
| GFLVLEGFLSAEECV | 16 | Q5SRE7 | |
| GGSAVDAAIAALLCV | 61 | P36268 | |
| SAGAGRTGCFIVIDI | 1096 | P28827 | |
| VHVLCGFIAGLESEF | 376 | Q6QHF9 | |
| AACAIGGFLASLTVV | 166 | Q8NGX6 | |
| SEIFGGLDICAVEAL | 361 | P17600 | |
| AELTFCTGDIITVFG | 976 | O15034 | |
| SAVVTDGGDLFVCGL | 61 | Q9UGK8 | |
| LTGCHLSVDVVLGDV | 571 | Q7Z4K8 | |
| FEDLTVDCLGHAGLV | 336 | Q92526 | |
| AVVGEIADGLARACA | 696 | Q8IYR2 | |
| TVFCGHLGKVELASV | 56 | Q86VL8 | |
| GTAALACVFLGVTVD | 346 | Q8WUG5 | |
| VVDVILGAFGACAAS | 1086 | O14841 | |
| GHGAAVSCVAISTEL | 2551 | Q6ZNJ1 | |
| CQIGLSVFSAIEGEA | 56 | Q8NA58 | |
| ACIAFLETLGGVTAV | 386 | Q7Z3Q1 | |
| GECVSVGSFINIEEI | 921 | O43166 | |
| HFSGVALGEACTIVL | 361 | P78371 | |
| GHEEVVTLLLEFGAC | 946 | Q9C0D5 | |
| LHLEEKTCVVGFAGL | 561 | Q9Y4R8 | |
| GADICGFVAETTEEL | 631 | P14410 | |
| VAGLHEVARCVDAGS | 1126 | Q9NQW1 | |
| GDTLTVLVCDGFEAS | 1181 | Q14160 | |
| EDSVISLSGDHCIIG | 101 | P00441 | |
| DIHTGLSGSGVAFVC | 171 | Q53H96 | |
| CAEEGGTLVAIESEV | 991 | Q13018 | |
| ARAQVCGGFILHEAV | 591 | Q5JTZ9 | |
| VEGCTAHDLDSVAGV | 566 | P98171 | |
| VFCGHLGKLELDAVT | 61 | Q96FL8 | |
| AVVCQALGSEITGFL | 21 | O95968 | |
| FISVACISHVAAIGD | 371 | Q96P48 | |
| IFSAGCVIAELFTEG | 241 | Q99570 | |
| ALEGCTFTVEGAGLT | 616 | P21980 | |
| ACVHEGIYEEGISIL | 71 | Q12933 | |
| CGGALVSEEAVLTAA | 326 | Q2L4Q9 | |
| VSEEAVLTAAHCFIG | 331 | Q2L4Q9 | |
| GGCVSISLEVIFRDH | 156 | Q96B21 | |
| AEGFSQDLGCDHILV | 736 | Q8TCY9 | |
| VHTECVAGVVGRADL | 161 | Q5T4D3 | |
| QAAGCFVGVVLSSEL | 301 | Q8N0X7 | |
| AGVVALDRVFHVGCF | 291 | Q15654 | |
| DVSEVIFGHVLAAGC | 51 | Q9BWD1 | |
| DCGAISFLDVVGVRS | 661 | O43511 | |
| VHVFGLCATALVTDV | 136 | Q6T4P5 | |
| IGGEVFAECLSDSAI | 341 | Q15796 | |
| TFSGHEDCVRGLAIL | 186 | Q9Y263 | |
| IIFSSGGEVKCEFEH | 726 | P53804 | |
| AVCSGEITDSAGVVL | 591 | Q53EL9 | |
| LEGTSCIAGVFVDAT | 4066 | Q15149 | |
| VVTCLDEARHGFESG | 231 | P22314 | |
| HVAVAGGLCAVAVFT | 11 | Q14656 | |
| IDLAHGGSCTVGVVS | 371 | Q9UDY6 | |
| CVTIVLDFGGILEGE | 141 | Q502W6 | |
| DIFSSNGGCLSDIVI | 6 | A2RRH5 | |
| SGVALEEGAHVLRCS | 716 | P48553 | |
| GVGDEVTVLFSVLAC | 6 | Q9BVT8 | |
| ECGAGFTEVAALLLH | 846 | Q9UEG4 | |
| TFLLAEACGFTGVVA | 371 | Q96T83 | |
| VCHTESAGVIAGAFV | 746 | Q9HD43 | |
| TEDVVRFEVGLHECG | 86 | P21754 | |
| VHGECIANLSFDITG | 371 | Q9Y4P3 | |
| FLNACVGVVEGDLAA | 266 | Q9UGI0 | |
| GGCELTVVIHDFTAC | 1656 | O75962 | |
| GGSAVDAAIAALLCV | 61 | P19440 | |
| VHEEFILCGGAETQV | 11 | Q9H6V9 | |
| LSVIEVCGHNFTAGD | 151 | P32418 | |
| SLIEVCGHGFIAGDL | 151 | P57103 | |
| AELAGVEICLEVGSG | 41 | Q9Y5N5 | |
| VSCLSIGVLDIFGFE | 511 | Q13459 | |
| LIDGGNETVAAICIA | 181 | Q9NQS3 |